Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7306 p20
3 July 2004

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· Pharmacy education
· Big Conversation
· Electronic prescribing
· Advertising
· Statins
· Free movement in Europe
· St John's wort
· The profession
· The Journal


Letters to the Editor

Advertising

Advertisement for Senokot may be misleading

From Mr C. Morris, MRPharmS

Ever since Senokot started its “contains safe, natural senna” campaign, I have fumed. Senna is natural but it is far from safe in long-term use.

I think that senna is a good laxative for short-term use but too many people use it continuously to the point where they have to take it since they have little or no bowel muscle tone.

Now we have a new advertisement. I have seen it twice and it took both times watching it to catch the small reference to constipation. Apparently “natural senna can promote digestive health”; it seems to be being sold as a health food supplement. These days everyone seems to go for vitamin supplements and healthy natural alternatives.

I was wondering whether anyone else had noticed it and whether anything could be done about possibly misleading advertisements.

C. Morris
Newquay, Cornwall

 

TIM BAXTER, medical affairs director, Reckitt Benckiser Healthcare, replies:

I am sorry to hear that Mr Morris is concerned that our advertisement for Senokot may encourage the inappropriate use of constipation remedies.

As leading manufacturers of over-the-counter medicines, Reckitt Benckiser Healthcare is always conscious of its duty to ensure that it does not promote any of its medicines in a way that might encourage them to be used inappropriately.

This advertisement was written to a specific brief that was wholly intended to target constipation sufferers. That is why it was ensured that the indication for relief of acute constipation only is made clear in the very first line of the script, and that the story then clearly shows the heroine suffering from constipation, taking our remedy, and then getting relief from her condition.

Like most major advertisers, Reckitt Benckiser Healthcare conducts extensive research before making a new television advertisement, using independent research companies and recognised and well-respected research techniques. In speaking to over 250 constipation sufferers, it did not encounter anyone who believed that the advertisement in any way suggested, promoted or endorsed the use of Senokot as a daily health supplement, or for any indication other than for the relief of constipation.

In addition to this research, before any advertisement can be broadcast, it must also satisfy two independent regulatory bodies that the film’s content meets all legal requirements. These two bodies are the Proprietary Association of Great Britain and the Broadcast Advertising Clearance Centre. Approval was obtained from both bodies before broadcast.

I hope this helps to reassure you that Reckitt Benckiser Healthcare takes its responsibilities as an advertiser extremely seriously, and that it has been careful to try to ensure that its advertising does not in any way encourage or condone the misuse of constipation remedies.

Send your letter to The Editor

Previous Topic (Electronic prescribing)
Next Topic (Statins)

Back to Top


©The Pharmaceutical Journal